Mork Capital Management’s Amgen AMGN Stock Holding History

Mork Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.18M	Sell	3,350 -520	-13%	-$185K	0.84%	49
2025 Q4	$1.27M	Hold	3,870	–	–	0.77%	42
2025 Q3	$1.09M	Hold	3,870	–	–	0.75%	59
2025 Q2	$1.08M	Hold	3,870	–	–	0.79%	59
2025 Q1	$1.21M	Hold	3,870	–	–	0.94%	37
2024 Q4	$1.01M	Buy	3,870 +400	+12%	+$119K	0.66%	82
2024 Q3	$1.12M	Hold	3,470	–	–	0.8%	63
2024 Q2	$1.08M	Hold	3,470	–	–	0.85%	51
2024 Q1	$987K	Hold	3,470	–	–	0.74%	74
2023 Q4	$999K	Buy	3,470 +260	+8%	+$70.8K	0.61%	69
2023 Q3	$863K	Hold	3,210	–	–	0.67%	67
2023 Q2	$713K	Hold	3,210	–	–	0.55%	99
2023 Q1	$776K	Sell	3,210 -1,290	-29%	-$317K	0.63%	94
2022 Q4	$1.18M	Hold	4,500	–	–	0.91%	33
2022 Q3	$1.01M	Hold	4,500	–	–	1%	35
2022 Q2	$1.09M	Hold	4,500	–	–	1%	38
2022 Q1	$1.09M	Hold	4,500	–	–	0.98%	44
2021 Q4	$1.01M	Buy	4,500 +100	+2%	+$21.1K	0.69%	92
2021 Q3	$936K	Hold	4,400	–	–	0.8%	74
2021 Q2	$1.07M	Hold	4,400	–	–	0.77%	71
2021 Q1	$1.09M	Hold	4,400	–	–	0.83%	66
2020 Q4	$1.01M	Buy	+4,400	New	+$1.01M	0.74%	66
2020 Q1	–	Sell	-4,000	Closed	-$964K	–	95
2019 Q4	$964K	Hold	4,000	–	–	0.69%	100
2019 Q3	$774K	Hold	4,000	–	–	0.71%	83
2019 Q2	$737K	Hold	4,000	–	–	0.68%	87
2019 Q1	$760K	Sell	4,000 -1,800	-31%	-$344K	0.71%	85
2018 Q4	$1.13M	Hold	5,800	–	–	1.05%	30
2018 Q3	$1.2M	Hold	5,800	–	–	0.97%	38
2018 Q2	$1.07M	Hold	5,800	–	–	0.95%	44
2018 Q1	$989K	Hold	5,800	–	–	0.95%	52
2017 Q4	$1.01M	Hold	5,800	–	–	0.67%	58
2017 Q3	$1.08M	Hold	5,800	–	–	0.88%	40
2017 Q2	$999K	Hold	5,800	–	–	0.86%	42
2017 Q1	$952K	Sell	5,800 -600	-9%	-$99.7K	0.85%	46
2016 Q4	$936K	Hold	6,400	–	–	0.66%	59
2016 Q3	$1.07M	Hold	6,400	–	–	1.02%	27
2016 Q2	$974K	Hold	6,400	–	–	0.97%	31
2016 Q1	$960K	Hold	6,400	–	–	0.94%	30
2015 Q4	$1.04M	Hold	6,400	–	–	1%	21
2015 Q3	$885K	Hold	6,400	–	–	1.04%	33
2015 Q2	$983K	Hold	6,400	–	–	1.16%	20
2015 Q1	$1.02M	Hold	6,400	–	–	1.18%	18
2014 Q4	$1.02M	Buy	+6,400	New	+$997K	0.78%	26

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Mork Capital Management's AMGN Position: Q1 2026 in Review

Mork Capital Management reduced its Amgen (AMGN) stake by 13% in Q1 2026, selling an estimated $185K and leaving 3,350 shares worth $1.18M. The position accounts for 0.84% of the portfolio, ranked #49.

Mork Capital Management first reported a position in AMGN in Q4 2014 and has held it in 43 quarters since. The position peaked at $1.27M in Q4 2025. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Mork Capital Management held 3,350 shares of Amgen worth $1.18M as of Q1 2026.
Mork Capital Management sold 520 Amgen shares in Q1 2026, an estimated $185K.
Amgen made up 0.84% of Mork Capital Management's portfolio in Q1 2026, its #49 holding.
Mork Capital Management first reported a position in Amgen in Q4 2014 and has held it in 43 quarters since.
Mork Capital Management's Amgen position peaked at $1.27M in Q4 2025.
3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Mork Capital Management's 13F filing for Q1 2026, filed 15 May 2026.